In the BioHarmony Drug Report Database

"Preview" Icon

Decitabine

Dacogen, Decitabine (decitabine) is a small molecule pharmaceutical. Decitabine was first approved as Dacogen on 2006-05-02. It is used to treat myelodysplastic syndromes in the USA. It has been approved in Europe to treat myeloid leukemia. It is known to target cytidine deaminase.

 

Trade Name

 

Dacogen
 

Common Name

 

decitabine
 

ChEMBL ID

 

CHEMBL1201129
 

Indication

 

myelodysplastic syndromes, myeloid leukemia
 

Drug Class

 

Nucleoside antiviral or antineoplastic agents, cytarabine or azarabine derivatives

Image (chem structure or protein)

Decitabine structure rendering